在使用混合溶剂的超临界抗溶剂过程中,过程参数对纳米微粒子形成的影响:通过基于实验设计的颗粒大小控制来提高telmisartan的溶解和口服生物可用性的应用
Eun-Sol Ha1, Heejun Park2, Ji-Su Jeong1
1College of Pharmacy and Research Institute for Drug Development, Pusan National University, 63 Busandaehak-ro, Geumjeong-gu, Busan 46241, Republic of Korea.
Pharmaceutics
|January 8, 2025
概括
超临界抗溶剂 (SAS) 处理产生无形的telmisartan纳米微粒. 优化SAS参数可以提高溶解度,并显著提高水溶性较差的药物的口服生物可用性.
科学领域:
- 制药技术 制药技术 制药技术
- 材料科学 材料科学 材料科学
- 化学工程是化学工程的重要组成部分.
背景情况:
- 泰尔米沙坦是一种水溶性较差的药物,需要增强的输送.
- 粒子工程对于提高这些化合物的生物利用性至关重要.
研究的目的:
- 调查超临界抗溶剂 (SAS) 过程参数对特尔米萨坦颗粒形成的影响.
- 评估颗粒大小对特尔米萨坦溶解性,溶解性和生物可用性的影响.
主要方法:
- 分数因数设计以优化SAS参数 (溶剂比,度,温度,压力,流量).
- 使用XRD和FT-IR进行固态特征.
- 在老鼠中评估动力溶解性,溶解性和体内口服生物可用性.
主要成果:
- 使用SAS.成功生产了无形特尔米沙坦纳米微粒 (200-2000nm).
- 药物溶液度和温度是影响颗粒大小的关键参数.
- 减少颗粒大小显著提高了动力溶解性,溶解率和口服生物可用性.
结论:
- 沙斯加工是一种有效的方法,用于生产无形telmisartan纳米微粒.
- 优化SAS参数可以控制粒子大小和形态.
- 这种方法显著提高了像特尔米萨坦这样的溶解不良药物的生物可用性.
相关概念视频
Factors Affecting Dissolution: Particle Size and Effective Surface Area
719
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
719
Factors Influencing Drug Absorption: Pharmaceutical Parameters
114
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
114
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
173
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
173
Factors Influencing Drug Absorption: Drug Dissolution
408
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
408
Factors Influencing Drug Absorption: Physicochemical Parameters
214
The physicochemical characteristics of drugs play a crucial role in formulating stable and bioavailable drug products. The solubility of a drug, governed by the varying pH along the GI tract and its dissociation constant (pKa), is pivotal in determining its ionization state and absorption rate. Notably, weak acids and bases remain unionized and are absorbed more rapidly.
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
214
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
281
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
281


